| T22 |
150-881 |
Sentence |
denotes |
In studies of patients on oral anticoagulation, ICH was shown to be the most devastating adverse event overall; these patients also had more extensive bleeding and increased mortality compared to patients with spontaneous ICH.5 , 6 While information on bleeding remains limited in COVID-19 patients, one study suggested that many COVID-19 patients with high risk of thrombosis were simultaneously at increased risk for bleeding.7 Although there have been recent publications about ischemic stroke in COVID-19 patients,1 literature regarding ICH in patients with COVID-19 is currently limited.8 , 9 We evaluated the presence of ICH in hospitalized COVID-19 patients and correlated imaging findings with their anticoagulation status. |
